132 related articles for article (PubMed ID: 7547252)
1. Are Japanese and European gastric cancer the same biological entity? An immunohistochemical study.
Livingstone JI; Yasui W; Tahara E; Wastell C
Br J Cancer; 1995 Oct; 72(4):976-80. PubMed ID: 7547252
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.
Lee KE; Lee HJ; Kim YH; Yu HJ; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
Jpn J Clin Oncol; 2003 Apr; 33(4):173-9. PubMed ID: 12810831
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical study of p53, c-erbB-2 and nm23 proteins in human gastric cancer].
Wei Z; Wu Y; Zhai Z
Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):378-81. PubMed ID: 10920922
[TBL] [Abstract][Full Text] [Related]
4. [Immunohistochemical analysis of c-erB-2 and nm23 expression in early gastric carcinoma].
Aoyagi K; Koufuji K; Kodama I; Ohta J; Takamiya H; Mizutani K; Takeda J; Shirouzu K
Nihon Shokakibyo Gakkai Zasshi; 1996 Sep; 93(9):613-9. PubMed ID: 8965386
[TBL] [Abstract][Full Text] [Related]
5. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
[TBL] [Abstract][Full Text] [Related]
6. [A study on the relationship between clinicopathological findings of gastric cancer and its biological behavior such as DNA ploidy pattern and immunohistochemical staining of PCNA, laminin, p53 and nm 23].
Shiroko T; Saji S; Kawaguchi Y; Kageyama T; Kunieda K; Umemoto T
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():118-23. PubMed ID: 7611773
[TBL] [Abstract][Full Text] [Related]
7. Relations of nm23 expression to clinicopathologic variables and proliferative activity of gastric cancer lesions.
Nakamura T; Tabuchi Y; Ohno M
Cancer Detect Prev; 1998; 22(3):246-50. PubMed ID: 9618047
[TBL] [Abstract][Full Text] [Related]
8. p53, c-erbB-2 and nm23 expression have no prognostic significance in primary pulmonary adenocarcinoma.
MacKinnon M; Kerr KM; King G; Kennedy MM; Cockburn JS; Jeffrey RR
Eur J Cardiothorac Surg; 1997 May; 11(5):838-42. PubMed ID: 9196297
[TBL] [Abstract][Full Text] [Related]
9. NM23 in Ovarian Cancer. Correlation with clinicopathological and biochemical parameters.
Ferrandina G; Scambia G; Marone M; Benedetti Panici P; Giannitelli C; Pernisco S; Coronetta F; Mancuso S
Ann N Y Acad Sci; 1996 Apr; 784():509-12. PubMed ID: 8651607
[No Abstract] [Full Text] [Related]
10. Evaluation of the epidermal growth factor receptor (EGFR) and c-erbB-2 in superspreading-type and penetrating-type gastric carcinoma.
Aoyagi K; Kohfuji K; Yano S; Murakami N; Miyagi M; Takeda J; Shirouzu K
Kurume Med J; 2001; 48(3):197-200. PubMed ID: 11680933
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical examinations (Ki67, p53, nm23) and DNA cytophotometry in bladder cancer.
Krause FS; Feil G; Bichler KH
Anticancer Res; 2000; 20(6D):5023-8. PubMed ID: 11326661
[TBL] [Abstract][Full Text] [Related]
12. Analysis of oncogenes and tumor suppressor genes in human breast cancer.
Yamashita H; Kobayashi S; Iwase H; Itoh Y; Kuzushima T; Iwata H; Itoh K; Naito A; Yamashita T; Masaoka A
Jpn J Cancer Res; 1993 Aug; 84(8):871-8. PubMed ID: 8104920
[TBL] [Abstract][Full Text] [Related]
13. [Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior].
Ji SQ; Hua YW; Zhuang J; Gao Y; Kong Y; Han SL; Shao YF
Ai Zheng; 2002 Jun; 21(6):619-24. PubMed ID: 12452062
[TBL] [Abstract][Full Text] [Related]
14. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53 and NDP-K/nm23 in gastric carcinomas--association with metastasis and clinicopathologic parameters.
Kim KM; Lee A; Chae HS; Shim SI
J Korean Med Sci; 1995 Dec; 10(6):406-13. PubMed ID: 8924224
[TBL] [Abstract][Full Text] [Related]
16. nm23 in the primary and metastatic sites of gastric carcinoma. Relation to AFP-producing carcinoma.
Kumar Dhar D; Kubota H; Tabara H; Kotoh T; Monden N; Igarashi M; Kohno H; Nagasue N
Oncology; 1999; 56(2):122-8. PubMed ID: 9949298
[TBL] [Abstract][Full Text] [Related]
17. The abundance of NM23-H1 mRNA is related with in situ microenvironment and intrahepatic metastasis in hepato-cellular carcinoma.
Zheng XY; Ling ZY; Tang ZY; Liu YK; Feng XL; Zhuang W
J Exp Clin Cancer Res; 1998 Sep; 17(3):337-41. PubMed ID: 9894772
[TBL] [Abstract][Full Text] [Related]
18. Expression of genetic markers in lymph node metastases compared with their primary tumours in head and neck cancer.
Takes RP; Baatenburg de Jong RJ; Wijffels K; Schuuring E; Litvinov SV; Hermans J; van Krieken JH
J Pathol; 2001 Jul; 194(3):298-302. PubMed ID: 11439361
[TBL] [Abstract][Full Text] [Related]
19. Protein markers in colorectal cancer: predictors of liver metastasis.
Berney CR; Fisher RJ; Yang J; Russell PJ; Crowe PJ
Ann Surg; 1999 Aug; 230(2):179-84. PubMed ID: 10450731
[TBL] [Abstract][Full Text] [Related]
20. Correlates of urokinase-type plasminogen activator in colorectal cancer: positive relationship with nm23 and c-erbB-2 protein expression.
Berney CR; Yang J; Fisher RJ; Russell PJ; Crowe PJ
Oncol Res; 1998; 10(1):47-54. PubMed ID: 9613457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
